{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T18:12:37Z","timestamp":1791655957521,"version":"4.3.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00415-026-13887-x","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T08:14:15Z","timestamp":1780733655000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and safety of calcitonin gene-related peptide monoclonal antibodies for cluster headache: a systematic review and frequentist-Bayesian meta-analysis"],"prefix":"10.1007","volume":"273","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8972-8329","authenticated-orcid":false,"given":"Lu","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pantila","family":"Kulachai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Ying","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Dan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,6]]},"reference":[{"issue":"1","key":"13887_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1474-4422(17)30405-2","volume":"17","author":"J Hoffmann","year":"2018","unstructured":"Hoffmann J, May A (2018) Diagnosis, pathophysiology, and management of cluster headache. Lancet Neurol 17(1):75\u201383","journal-title":"Lancet Neurol"},{"issue":"1","key":"13887_CR2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/head.14021","volume":"61","author":"MJ Burish","year":"2021","unstructured":"Burish MJ, Pearson SM, Shapiro RE et al (2021) Cluster headache is one of the most intensely painful human conditions: results from the international cluster headache questionnaire. Headache 61(1):117\u2013124","journal-title":"Headache"},{"issue":"1","key":"13887_CR3","first-page":"1","volume":"38","author":"Headache classification committee of the international headache society (IHS)","year":"2018","unstructured":"Headache classification committee of the international headache society (IHS) (2018) The international classification of headache disorders, 3rd edition. Cephalalgia 38(1):1\u2013211","journal-title":"Cephalalgia"},{"key":"13887_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e2407","volume":"344","author":"AD Nesbitt","year":"2012","unstructured":"Nesbitt AD, Goadsby PJ (2012) Cluster headache. BMJ 344:e2407","journal-title":"BMJ"},{"issue":"1","key":"13887_CR5","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1526-4610.2011.02028.x","volume":"52","author":"TD Rozen","year":"2012","unstructured":"Rozen TD, Fishman RS (2012) Cluster headache in the United States of America: demographics, clinical characteristics, triggers, suicidality, and personal burden. Headache 52(1):99\u2013113","journal-title":"Headache"},{"issue":"6","key":"13887_CR6","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/j.1468-2982.2007.01330.x","volume":"27","author":"RM Jensen","year":"2007","unstructured":"Jensen RM, Lyngberg A, Jensen RH (2007) Burden of cluster headache. Cephalalgia 27(6):535\u2013541","journal-title":"Cephalalgia"},{"issue":"10","key":"13887_CR7","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1111\/ene.15956","volume":"30","author":"A May","year":"2023","unstructured":"May A, Evers S, Goadsby PJ et al (2023) European academy of neurology guidelines on the treatment of cluster headache. Eur J Neurol 30(10):2955\u20132979","journal-title":"Eur J Neurol"},{"issue":"1","key":"13887_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s40265-021-01658-z","volume":"82","author":"HC Diener","year":"2022","unstructured":"Diener HC, May A (2022) Drug treatment of cluster headache. Drugs 82(1):33\u201342","journal-title":"Drugs"},{"issue":"1","key":"13887_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-023-01660-8","volume":"24","author":"NLT Lund","year":"2023","unstructured":"Lund NLT, Petersen AS, Fronczek R et al (2023) Current treatment options for cluster headache: limitations and the unmet need for better and specific treatments\u2014a consensus article. J Headache Pain 24(1):121","journal-title":"J Headache Pain"},{"issue":"6","key":"13887_CR10","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41582-018-0003-1","volume":"14","author":"L Edvinsson","year":"2018","unstructured":"Edvinsson L, Haanes KA, Warfvinge K et al (2018) CGRP as the target of new migraine therapies: successful translation from bench to clinic. Nat Rev Neurol 14(6):338\u2013350","journal-title":"Nat Rev Neurol"},{"issue":"Pt 3","key":"13887_CR11","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/brain\/117.3.427","volume":"117","author":"PJ Goadsby","year":"1994","unstructured":"Goadsby PJ, Edvinsson L (1994) Human in vivo evidence for trigeminovascular activation in cluster headache: neuropeptide changes and effects of acute attacks therapies. Brain 117(Pt 3):427\u2013434","journal-title":"Brain"},{"issue":"10","key":"13887_CR12","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1001\/jamaneurol.2018.1675","volume":"75","author":"ALH Vollesen","year":"2018","unstructured":"Vollesen ALH, Snoer A, Beske RP et al (2018) Effect of infusion of calcitonin gene-related peptide on cluster headache attacks: a randomized clinical trial. JAMA Neurol 75(10):1187\u20131197","journal-title":"JAMA Neurol"},{"issue":"1","key":"13887_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-022-01431-x","volume":"23","author":"S Sacco","year":"2022","unstructured":"Sacco S, Amin FM, Ashina M et al (2022) European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention: 2022 update. J Headache Pain 23(1):67","journal-title":"J Headache Pain"},{"issue":"4","key":"13887_CR14","doi-asserted-by":"publisher","DOI":"10.1177\/03331024231159366","volume":"43","author":"F Haghdoost","year":"2023","unstructured":"Haghdoost F, Puledda F, Garcia-Azorin D et al (2023) Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: a systematic review and network meta-analysis of phase 3 randomised controlled trials. Cephalalgia 43(4):3331024231159366","journal-title":"Cephalalgia"},{"issue":"2","key":"13887_CR15","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1056\/NEJMoa1813440","volume":"381","author":"PJ Goadsby","year":"2019","unstructured":"Goadsby PJ, Dodick DW, Leone M et al (2019) Trial of galcanezumab in prevention of episodic cluster headache. N Engl J Med 381(2):132\u2013141","journal-title":"N Engl J Med"},{"issue":"9","key":"13887_CR16","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1177\/0333102420905321","volume":"40","author":"DW Dodick","year":"2020","unstructured":"Dodick DW, Goadsby PJ, Lucas C et al (2020) Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache: results from 3-month double-blind treatment. Cephalalgia: Int J Headache 40(9):935\u2013948","journal-title":"Cephalalgia: Int J Headache"},{"issue":"7","key":"13887_CR17","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1001\/jamaneurol.2025.1317","volume":"82","author":"RH Jensen","year":"2025","unstructured":"Jensen RH, Tassorelli C, Tepper SJ et al (2025) Efficacy and safety of eptinezumab in episodic cluster headache: a randomized clinical trial. JAMA Neurol 82(7):706\u2013714","journal-title":"JAMA Neurol"},{"issue":"6","key":"13887_CR18","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.16318","volume":"8","author":"J Mecklenburg","year":"2025","unstructured":"Mecklenburg J, Gaul C, Fitzek M et al (2025) Erenumab for chronic cluster headache: a randomized clinical trial. JAMA Netw Open 8(6):e2516318","journal-title":"JAMA Netw Open"},{"key":"13887_CR19","unstructured":"Teva Branded Pharmaceutical Products R&D, Inc (2021) A multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study comparing the efficacy and safety of 2 dose regimens (intravenous\/subcutaneous and subcutaneous) of TEV-48125 versus placebo for the prevention of epidosic cluster headache: NCT02945046 [R]. clinicaltrials.gov"},{"key":"13887_CR20","unstructured":"Teva Branded Pharmaceutical Products R&D, Inc. (2021) A multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study comparing the efficacy and safety of 2 dose regimens (intravenous\/subcutaneous and subcutaneous) of TEV-48125 versus placebo for the prevention of chronic cluster headache: NCT02964338 [R]. clinicaltrials.gov"},{"key":"13887_CR21","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.2147\/JPR.S222604","volume":"13","author":"L Pellesi","year":"2020","unstructured":"Pellesi L, De Icco R, Al-Karagholi MAM et al (2020) Reducing episodic cluster headaches: focus on galcanezumab. J Pain Res 13:1591\u20131599","journal-title":"J Pain Res"},{"issue":"3","key":"13887_CR22","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1177\/0333102417741297","volume":"39","author":"S Khan","year":"2019","unstructured":"Khan S, Olesen A, Ashina M (2019) CGRP, a target for preventive therapy in migraine and cluster headache: systematic review of clinical data. Cephalalgia 39(3):374\u2013389","journal-title":"Cephalalgia"},{"issue":"1","key":"13887_CR23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s10194-020-1085-x","volume":"21","author":"Y Yang","year":"2020","unstructured":"Yang Y, Wang Z, Gao B et al (2020) Different doses of galcanezumab versus placebo in patients with migraine and cluster headache: a meta-analysis of randomized controlled trials. J Headache Pain 21(1):14","journal-title":"J Headache Pain"},{"issue":"1","key":"13887_CR24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/01616412.2024.2440022","volume":"47","author":"MB da Silva","year":"2025","unstructured":"da Silva MB, de Oliveira Ferreira DBC, Mendieta CD et al (2025) Efficacy and safety of galcanezumab for cluster headache preventive treatment: a systematic review and meta-analysis. Neurol Res 47(1):63\u201376","journal-title":"Neurol Res"},{"key":"13887_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71","journal-title":"BMJ"},{"key":"13887_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898","journal-title":"BMJ"},{"issue":"7","key":"13887_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010247","volume":"6","author":"J IntHout","year":"2016","unstructured":"IntHout J, Ioannidis JPA, Rovers MM et al (2016) Plea for routinely presenting prediction intervals in meta-analysis. BMJ Open 6(7):e010247","journal-title":"BMJ Open"},{"issue":"4","key":"13887_CR28","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","volume":"22","author":"S Balduzzi","year":"2019","unstructured":"Balduzzi S, R\u00fccker G, Schwarzer G (2019) How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health 22(4):153\u2013160","journal-title":"Evid Based Ment Health"},{"key":"13887_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v093.i06","volume":"93","author":"C R\u00f6ver","year":"2020","unstructured":"R\u00f6ver C (2020) Bayesian random-effects meta-analysis using the bayesmeta R package. J Stat Softw 93:1\u201351","journal-title":"J Stat Softw"},{"issue":"1","key":"13887_CR30","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","volume":"61","author":"J Wetterslev","year":"2008","unstructured":"Wetterslev J, Thorlund K, Brok J et al (2008) Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. J Clin Epidemiol 61(1):64\u201375","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"13887_CR31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12874-017-0315-7","volume":"17","author":"J Wetterslev","year":"2017","unstructured":"Wetterslev J, Jakobsen JC, Gluud C (2017) Trial sequential analysis in systematic reviews with meta-analysis. BMC Med Res Methodol 17(1):39","journal-title":"BMC Med Res Methodol"},{"key":"13887_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-9-86","volume":"9","author":"J Wetterslev","year":"2009","unstructured":"Wetterslev J, Thorlund K, Brok J et al (2009) Estimating required information size by quantifying diversity in random-effects model meta-analyses. BMC Med Res Methodol 9:86","journal-title":"BMC Med Res Methodol"},{"issue":"7","key":"13887_CR33","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1046\/j.1468-2982.2003.00531.x","volume":"23","author":"AIM Nilsson Remahl","year":"2003","unstructured":"Nilsson Remahl AIM, Laudon Meyer E, Cordonnier C et al (2003) Placebo response in cluster headache trials: a review. Cephalalgia 23(7):504\u2013510","journal-title":"Cephalalgia"},{"issue":"2","key":"13887_CR34","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJMoa1610384","volume":"376","author":"SW Powers","year":"2017","unstructured":"Powers SW, Coffey CS, Chamberlin LA et al (2017) Trial of amitriptyline, topiramate, and placebo for pediatric migraine. N Engl J Med 376(2):115\u2013124","journal-title":"N Engl J Med"},{"issue":"4","key":"13887_CR35","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1001\/jamapediatrics.2019.5856","volume":"174","author":"C Locher","year":"2020","unstructured":"Locher C, Kossowsky J, Koechlin H et al (2020) Efficacy, safety, and acceptability of pharmacologic treatments for pediatric migraine prophylaxis: a systematic review and network meta-analysis. JAMA Pediatr 174(4):341\u2013349","journal-title":"JAMA Pediatr"},{"issue":"4","key":"13887_CR36","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/head.14292","volume":"62","author":"DW Dodick","year":"2022","unstructured":"Dodick DW, Goadsby PJ, Ashina M et al (2022) Challenges and complexities in designing cluster headache prevention clinical trials: a narrative review. Headache 62(4):453\u2013472","journal-title":"Headache"},{"issue":"3","key":"13887_CR37","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/bph.15585","volume":"179","author":"ML Garelja","year":"2022","unstructured":"Garelja ML, Walker CS, Hay DL (2022) CGRP receptor antagonists for migraine: are they also AMY1 receptor antagonists? Br J Pharmacol 179(3):454\u2013459","journal-title":"Br J Pharmacol"},{"issue":"1","key":"13887_CR38","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/head.14234","volume":"62","author":"MJA L\u00e1inez","year":"2022","unstructured":"L\u00e1inez MJA, Schoenen J, Stroud C et al (2022) Tolerability and safety of galcanezumab in patients with chronic cluster headache with up to 15 months of galcanezumab treatment. Headache 62(1):65\u201377","journal-title":"Headache"},{"issue":"5","key":"13887_CR39","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S1474-4422(25)00065-1","volume":"24","author":"C Tassorelli","year":"2025","unstructured":"Tassorelli C, Jensen RH, Goadsby PJ et al (2025) Long-term safety, tolerability, and efficacy of eptinezumab in chronic cluster headache (CHRONICLE): an open-label safety trial. Lancet Neurol 24(5):429\u2013440","journal-title":"Lancet Neurol"},{"issue":"7","key":"13887_CR40","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/S1474-4422(24)00143-1","volume":"23","author":"AS Petersen","year":"2024","unstructured":"Petersen AS, Lund N, Goadsby PJ et al (2024) Recent advances in diagnosing, managing, and understanding the pathophysiology of cluster headache. Lancet Neurol 23(7):712\u2013724","journal-title":"Lancet Neurol"},{"issue":"9","key":"13887_CR41","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s11916-022-01070-6","volume":"26","author":"ST Chen","year":"2022","unstructured":"Chen ST, Wu JW (2022) CGRP-targeted therapy for episodic and chronic cluster headache. Curr Pain Headache Rep 26(9):667\u2013675","journal-title":"Curr Pain Headache Rep"},{"issue":"11-12","key":"13887_CR42","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1177\/03331024221103509","volume":"42","author":"R Riesenberg","year":"2022","unstructured":"Riesenberg R, Gaul C, Stroud CE et al (2022) Long-term open-label safety study of galcanezumab in patients with episodic or chronic cluster headache. Cephalalgia 42(11\u201312):1225\u20131235","journal-title":"Cephalalgia"},{"issue":"3","key":"13887_CR43","doi-asserted-by":"publisher","DOI":"10.1177\/03331024231226181","volume":"44","author":"R Lamas P\u00e9rez","year":"2024","unstructured":"Lamas P\u00e9rez R, Mill\u00e1n-V\u00e1zquez M, Gonz\u00e1lez-Oria C (2024) Efficacy and safety of galcanezumab as chronic cluster headache preventive treatment under real world conditions: observational prospective study. Cephalalgia 44(3):3331024231226181","journal-title":"Cephalalgia"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13887-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-13887-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13887-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T08:02:08Z","timestamp":1783497728000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-026-13887-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,6]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["13887"],"URL":"https:\/\/doi.org\/10.1007\/s00415-026-13887-x","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,6]]},"assertion":[{"value":"19 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Our study was a systematic review and meta-analysis, and was exempt from review and approval by the research ethics committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"371"}}